Why Is Everyone Talking About Zomedica Stock?
If you've ever taken your pet to the vet for something other than a routine checkup, you've witnessed the amazing perceptiveness of veterinarians. Even though their patients can't communicate their ailments -- at least, my labradors never could -- vets still find a way to diagnose the problem. And soon, they'll have a powerful new tool that can make the process much faster and easier, thanks to Zomedica (NYSEMKT: ZOM).
Zomedica's ascent began in January of this year, when it announced the arrival of a new CEO, Robert Cohen. Shortly thereafter, Reddit traders piled into the stock, causing it to grow explosively and putting it on the map for the first time.
Since then, its price has remained quite high, and it's possible that it will exit penny-stock territory and become a more broadly appealing investment rather soon. That assumes vets actually flock to purchase its much-anticipated diagnostic hardware, however.
Source Fool.com
